Contineum Therapeutics (CTNM) Shares Outstanding (2023 - 2026)
Contineum Therapeutics (CTNM) reported Weighted Average Shares Outstanding of 38.39 million for Q3 2026, up 36.5% from 28.12 million a year earlier and up 2.5% from the prior quarter.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Shares Outstanding (2023 - 2026) Analysis & Trends
For FY2025, Contineum Therapeutics posted Weighted Average Shares Outstanding of 27.7 million, up 43.1% from FY2024.
- By year, Weighted Average Shares Outstanding came in at 19.35 million in FY2024 (+736.7%) and 2.31 million in FY2023.
- The Q3 2026 figure ranks as the highest quarterly Weighted Average Shares Outstanding in data going back to Q1 2023.
- Year over year, Weighted Average Shares Outstanding has now increased in each of the last eight quarters, with growth averaging 239.7% over the last eight quarters.
- The year-over-year growth in Weighted Average Shares Outstanding has ranged between 4.0% (Q1 2024) and 991.9% (Q1 2025) over the last five years.
- Per Business Quant data, the three quarters before Q3 2026 came in at 37.47 million (Q2 2026), 37.34 million (Q1 2026) and 27.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.94 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.55 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Contineum Therapeutics | 405.40 Mn | -584.86 Mn | - | 38.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 38.39 Mn |
| Jun 30, 2026 | 37.47 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Dec 31, 2025 | 27.70 Mn |
| Sep 30, 2025 | 28.12 Mn |
| Jun 30, 2025 | 25.90 Mn |
| Mar 31, 2025 | 25.87 Mn |
| Dec 31, 2024 | 19.35 Mn |
| Sep 30, 2024 | 25.73 Mn |
| Jun 30, 2024 | 23.36 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 2.33 Mn |
| Jun 30, 2023 | 2.30 Mn |
| Mar 31, 2023 | 2.28 Mn |
API Access
Contineum Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CTNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();